Evolving trends in the epidemiologic factors of heart failure: Rationale for preventive strategies and comprehensive disease management

American Heart Journal

Volumn 133, Issue 6, 1997, Pages 703-712

  Massie, B M ^a   Shah, N B ^a  

^a SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; CONGESTIVE HEART FAILURE; EUROPE; HUMAN; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; UNITED STATES;

EID: 0030808080     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(97)70173-X     Document Type: Article

References (52)

1. Centers for Disease Control and Prevention Trends in ischemic heart disease mortality United States, 1980-1988 MMWR 41 1992 548 549 555-6
2. Centers for Disease Control and Prevention Cerebrovascular disease mortality and Medicare hospitalization United States, 1980-1990 MMWR 41 1992 477 480
3. RF. Gillum Trends in acute MI and coronary heart disease death in the United States J Am Coll Cardiol 23 1994 1273 1277
4. S Yusuf T Thom RD. Abbott Changes in hypertension treatment and in CHF mortality in the United States Hypertension 13 suppl 5 1989 I74 I79
5. JK Ghali R Cooper E. Ford Trends in hospitalization rates for heart failure in the United States. 1973-1986: evidence for increasing population prevalence Arch Intern Med 150 1990 769 773
6. PA Sytkowski WB Kannel RB. D'Agostino Changes in risk factors and the decline in mortality from cardiovascular disease: the Framingham Heart Study N Engl J Med 322 1990 1635 1641
7. PG McGovern JS Pankow E Shahar KM Doliszny AR Folsom H Blackburn Recent trends in acute coronary heart disease. Mortality, morbidity, medical care, risk factors N Engl J Med 334 1996 884 890
8. American Heart Association Heart and stroke facts: 1996 statistical supplement 1996 American Heart Association Dallas 15
9. American College of Cardiology/American Heart Association Committee on Evaluation and Management of Heart Failure Guidelines for the evaluation and management of heart failure J Am Coll Cardiol 26 1995 1376 1398
10. H. Eriksson Heart failure: a growing public health problem J Intern Med 237 1995 135 141
11. M Yamani BM. Massie Congestive heart failure: insights from epidemiology, implications for treatment Mayo Clin Proc 68 1993 1214 1218
12. RJ Rodeheffer SJ Jacobsen BJ Gersh TE Kottke HA McCann KR Bailey The incidence and prevalence of congestive heart failure in Rochester, Minnesota Mayo Clin Proc 68 1993 1143 1150
13. PA McKee WP Castelli PM McNamara WB. Kannel The natural history of congestive heart failure: The Framingham study N Engl J Med 285 1971 1441 1446
14. KKL Ho KM Anderson WB Kannel W Grossman D. Levy Survival after the onset of congestive heart failure in Framingham Heart Study subjects Circulation 88 1993 107 115
15. H Eriksson K Svardsudd B Larsson LO Ohlson G Tibblin L Welin Risk factors for heart failure in the general population: the study of men born in 1913 Eur Heart J 10 1989 647 656
16. J Remes A Reunanen A Aromaa K. Pyorala Incidence of heart failure in eastern Finland: a population-based surveillance study Eur Heart J 20 1992 301 306
17. DD Schocken MI Arrieta PE. Leaverton Prevalence and mortality rate of congestive heart failure in the United States J Am Coll Cardiol 20 1992 301 306
18. J Parameshwar MM Shackell A Richardson PA Poole-Wilson GC. Sutton Prevalence of heart failure in three general practices in north west London Br J Gen Pract 42 1992 287 289
19. RO Bonow JE. Udelson Left ventricular diastolic dysfunction as a cause of congestive heart failure. Mechanisms and management Ann Intern Med 117 1992 502 510
20. MM McDermott J Feinglass J Sy M. Gheorghiade Hospitalized congestive heart failure patients with preserved versus abnormal left ventricular systolic function: clinical characteristics and drug therapy Am J Med 99 1995 629 635
21. WB Kannel K Ho T. Thom Changing epidemiological features of cardiac failure Eur Heart J 72 Suppl 1994 S3 S9
22. B Anderson F. Waagstein Spectrum and outcome of congestive heart failure in a hospitalized population Am Heart J 126 1993 632 640
23. Centers for Disease Control and Prevention Mortality from congestive heart failure United States, 1980-1990 MMWR 5 1994 77 81
24. RF. Gillum Heart failure in the United States 1970-1985 Am Heart J 113 1987 1043 1045
25. D. Graham Utilization of short-stay hospitals. Vital and Health Statistics Series 13: data from the National Health Survey 83 1985 US Government Printing Office Washington, DC 1 58
26. EJ. Graves National hospital discharge survey: annual summary, 1988. Vital and health statistics Series 13: Data from National Health Survey 106 1991 1 55
27. EJ. Graves National Hospital Discharge Survey: annual summary, 1993. Vital and Health Statistics Series 13: Data from National Health Survey 121 1995 1 63
28. The CONSENSUS Trial study group Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS) N Engl J Med 316 1987 1429 1435
29. JN Cohn DG Archibald S Ziesche JA Franciosa WE Harston FE Tristani Effect of vasodilator therapy on mortality in chronic congestive heart failure: results of a Veterans Administration cooperative study N Engl J Med 314 1986 1547 1552
30. The SOLVD Investigators Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure N Engl J Med 325 1991 293 302
31. M Packer JR Carver RJ Rodeheffer RJ Ivanhoe R DiBianco SM Zeldis Effect of oral milrinone on mortality in severe chronic heart failure N Engl J Med 325 1991 1468 1475
32. JN Cohn G Johnson S Ziesche F Cobb G Francis F Tristani A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure N Engl J Med 325 1991 303 310
33. CIBIS Investigators and Committees A randomized trial of beta-blockade in heart failure: the cardiac insufficiency bisoprolol study (CIBIS) Circulation 90 1994 1765 1773
34. M Packer CM O'Connor JK Ghali ML Pressler PE Carson RN Belkin Effect of amlodipine on morbidity and mortality in severe chronic heart failure N Engl J Med 335 1996 1107 1114
35. SN Singh RD Fletcher SG Fisher BN Singh HD Lewis PC Deedwania Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia N Engl J Med 333 1995 77 82
36. WG Stevenson LW Stevenson HR Middlekauff GC Fonarow MA Hamilton MA Woo Improving survival for patients with advanced heart failure: a study of 737 consecutive patients J Am Coll Cardiol 26 1995 1417 1423
37. A Di Lenarda G Secoli A Perkan D Gregori G Lardieri B Pinamonti Changing mortality in dilated cardiomyopathy. The Heart Muscle Disease Study Group Br Heart J 72 Suppl 6 1994 S46 S51
38. MW Rich V Beckham C Wittenberg CL Leven KE Freedland RM. Carney A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure N Engl J Med 333 1995 1190 1195
39. SD Paul KM Kuntz KA Eagle MC. Weinstein Costs and effectiveness of ACE inhibition in patients with congestive heart failure Arch Intern Med 154 1994 1143 1149
40. JB O'Connell MR. Bristow Economic impact of heart failure in the United States: time for a different approach J Heart Lung Transplant 13 1994 s107 s112
41. Veterans Administration cooperative study group on antihypertensive agents Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90-115 mm Hg J Am Med Assoc 213 1970 1143 1152
42. SHEP Cooperative Research Group Prevention of stroke by antihypertensive treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP) J Am Med Assoc 265 1991 3255 3264
43. B Dahlöf LH Lindholm L Hannson B Scherstén T Ekbom P-O. Wester Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP Hypertension) Lancet 338 1991 1281 1285
44. J Kjekshus T. Pedersen Lowering of cholesterol with simvastatin may prevent development of heart failure in patients with coronary heart disease [abstract] J Am Coll Cardiol 25 1995 282A
45. The SOLVD Investigators Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions N Engl J Med 327 1992 685 691
46. MA Pfeffer E Braunwald LA Moyé L Basta EJ Brown TE Cuddy Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after MI. Results of the Survival and Ventricular Enlargement Trial N Engl J Med 327 1992 669 677
47. F Waagstein MW Bristow K Swedberg F Camerini MB Fowler MA Silver Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy Lancet 343 1993 1441 1446
48. WS Colucci M Packer MR Bristow EM Gilbert JN Cohn MB Fowler Carvedilol inhibits clinical progression in patients with mild heart failure Circulation 94 1996 2800 2807
49. MB Fowler EM Gilbert JN Cohn MA Bristow WS Colucci NH Shusterman Effects of carvedilol on cardiovascular hospitalizations in patients with chronic heart failure J Am Coll Cardiol 27 1996 169A
50. JJ. Ferguson Meeting highlights. Digitalis in heart failure Circulation 94 1996 3
51. R Kornowski D Zeeli M Averbuch A Finkelstein D Schwartz M Moshkovitz Intensive home-care surveillance prevents hospitalization and improves morbidity rates among elderly patients with severe congestive heart failure Am Heart J 129 1995 762 766
52. NB Shah E Der C Ruggerio P Heidenreich BM. Massie Prevention of hospitalizations for heart failure by an interactive home monitoring program [abstract] Circulation 94 Suppl I 1996 I194